Nakagawa M - Search Results

1

Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion.

Ravilla R, Coleman HN, Chow CE, Chan L, Fuhrman BJ, Greenfield WW, Robeson MS, Iverson K, Spencer H 3rd, Nakagawa M. Ravilla R, et al. Among authors: nakagawa m. Integr Cancer Ther. 2019 Jan-Dec;18:1534735419893063. doi: 10.1177/1534735419893063. Integr Cancer Ther. 2019. PMID: 31833799 Free PMC article. Clinical Trial.

2

T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia.

Nakagawa M, Stites DP, Farhat S, Judd A, Moscicki AB, Canchola AJ, Hilton JF, Palefsky JM. Nakagawa M, et al. Clin Diagn Lab Immunol. 1996 Mar;3(2):205-10. doi: 10.1128/cdli.3.2.205-210.1996. Clin Diagn Lab Immunol. 1996. PMID: 8991637 Free PMC article.

3

Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia.

Nakagawa M, Stites DP, Farhat S, Sisler JR, Moss B, Kong F, Moscicki AB, Palefsky JM. Nakagawa M, et al. J Infect Dis. 1997 Apr;175(4):927-31. doi: 10.1086/513992. J Infect Dis. 1997. PMID: 9086151

4

Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell clone.

Kim KH, Dishongh R, Santin AD, Cannon MJ, Bellone S, Nakagawa M. Kim KH, et al. Among authors: nakagawa m. Cancer Immun. 2006 Jun 30;6:9. Cancer Immun. 2006. PMID: 16808432

5

Detection of human papillomavirus type 16-specific T lymphocytes by a recombinant vaccinia virus-based enzyme-linked immunospot assay.

Kim KH, Greenfield W, Shotts E, Nakagawa M. Kim KH, et al. Among authors: nakagawa m. Clin Vaccine Immunol. 2007 Apr;14(4):362-8. doi: 10.1128/CVI.00460-06. Epub 2007 Feb 21. Clin Vaccine Immunol. 2007. PMID: 17314231 Free PMC article.

6

A favorable clinical trend is associated with CD8 T-cell immune responses to the human papillomavirus type 16 e6 antigens in women being studied for abnormal pap smear results.

Nakagawa M, Gupta SK, Coleman HN, Sellers MA, Banken JA, Greenfield WW. Nakagawa M, et al. J Low Genit Tract Dis. 2010 Apr;14(2):124-9. doi: 10.1097/LGT.0b013e3181c6f01e. J Low Genit Tract Dis. 2010. PMID: 20354421

7

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend.

Kim KH, Greenfield WW, Cannon MJ, Coleman HN, Spencer HJ, Nakagawa M. Kim KH, et al. Among authors: nakagawa m. Cancer Immunol Immunother. 2012 Jan;61(1):63-70. doi: 10.1007/s00262-011-1092-5. Epub 2011 Aug 13. Cancer Immunol Immunother. 2012. PMID: 21842207 Free PMC article.

8

Use of interferon-γ enzyme-linked immunospot assay to characterize novel T-cell epitopes of human papillomavirus.

Wang X, Greenfield WW, Coleman HN, James LE, Nakagawa M. Wang X, et al. Among authors: nakagawa m. J Vis Exp. 2012 Mar 8;(61):3657. doi: 10.3791/3657. J Vis Exp. 2012. PMID: 22434036 Free PMC article.

9

CD8 T-cell responses in incident and prevalent human papillomavirus types 16 and 18 infections.

Coleman HN, Moscicki AB, Farhat SN, Gupta SK, Wang X, Nakagawa M. Coleman HN, et al. Among authors: nakagawa m. ISRN Obstet Gynecol. 2012;2012:854237. doi: 10.5402/2012/854237. Epub 2012 Mar 4. ISRN Obstet Gynecol. 2012. PMID: 22523697 Free PMC article.

10

Distribution of human papillomavirus (HPV) types and anti-HPV T-cell immune responses among different racial/ethnic groups in Central Arkansas.

Nakagawa M, Spencer HJ, Coleman HN, Greenfield WW. Nakagawa M, et al. J Ark Med Soc. 2013 Jan;109(8):160-3. J Ark Med Soc. 2013. PMID: 23367687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,039 results

Search Page

Filters